BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18666046)

  • 1. Cytotoxic effects of haplamine and its major metabolites on human cancer cell lines.
    Ea S; Giacometti S; Ciccolini J; Akhmedjanova V; Aubert C
    Planta Med; 2008 Aug; 74(10):1265-8. PubMed ID: 18666046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of 14 alkaloids isolated from Haplophyllum A. Juss. for their cytotoxic properties.
    Jansen O; Akhmedjanova V; Angenot L; Balansard G; Chariot A; Ollivier E; Tits M; Frédérich M
    J Ethnopharmacol; 2006 Apr; 105(1-2):241-5. PubMed ID: 16330172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-species variability of haplamine metabolism and identification of its phase I metabolites from liver microsomes.
    Ea S; Bun SS; Aubert C; Akhmedjanova V; Ollivier E; Siv C; Bun H
    Planta Med; 2006 Nov; 72(14):1273-8. PubMed ID: 16983601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.
    Halloran CM; Ghaneh P; Shore S; Greenhalf W; Zumstein L; Wilson D; Neoptolemos JP; Costello E
    J Gene Med; 2004 May; 6(5):514-25. PubMed ID: 15133762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the chemosensitivity of pancreatic cancer cells by quantifying the expression levels of genes associated with the metabolism of gemcitabine and 5-fluorouracil.
    Kurata N; Fujita H; Ohuchida K; Mizumoto K; Mahawithitwong P; Sakai H; Onimaru M; Manabe T; Ohtsuka T; Tanaka M
    Int J Oncol; 2011 Aug; 39(2):473-82. PubMed ID: 21617862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells.
    Attoub S; Arafat K; Khalaf T; Sulaiman S; Iratni R
    Nutrients; 2018 May; 10(5):. PubMed ID: 29724012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
    Bernhaus A; Ozsvar-Kozma M; Saiko P; Jaschke M; Lackner A; Grusch M; Horvath Z; Madlener S; Krupitza G; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Invest New Drugs; 2009 Oct; 27(5):393-401. PubMed ID: 18841326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colossolactone-G synergizes the anticancer properties of 5-fluorouracil and gemcitabine against colorectal cancer cells.
    Algehani RA; Abou Khouzam R; Hegazy GA; Alamoudi AA; El-Halawany AM; El Dine RS; Ajabnoor GA; Al-Abbasi FA; Baghdadi MA; Elsayed I; Hattori M; Al-Abd AM
    Biomed Pharmacother; 2021 Aug; 140():111730. PubMed ID: 34062410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a simple HPLC method for assay of haplamine and its metabolites in plasma suitable for pharmacokinetic application in rats.
    Ea S; Aubert C; Giacometti S; Ciccolini J; Siv C; Bun H
    Biomed Chromatogr; 2008 Feb; 22(2):125-30. PubMed ID: 17703477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer.
    Onishi H; Morifuji Y; Kai M; Suyama K; Iwasaki H; Katano M
    Cancer Sci; 2012 Jul; 103(7):1272-9. PubMed ID: 22486854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC quantification of alkaloids from Haplophyllum extracts and comparison with their cytotoxic properties.
    Fiot J; Jansen O; Akhmedjanova V; Angenot L; Balansard G; Ollivier E
    Phytochem Anal; 2006; 17(5):365-9. PubMed ID: 17019939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.
    Bader Y; Hartmann J; Horvath Z; Saiko P; Grusch M; Madlener S; Maier S; Oehler L; Fritzer-Szekeres M; Heller N; Alken RG; Krupitza G; Szekeres T
    Cancer Lett; 2008 Feb; 259(2):231-9. PubMed ID: 18023527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activity of gamma-linolenic acid and cytotoxic drugs against pancreatic adenocarcinoma cell lines.
    Whitehouse PA; Cooper AJ; Johnson CD
    Pancreatology; 2003; 3(5):367-73; discussion 373-4. PubMed ID: 14526145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer.
    Ghadban T; Dibbern JL; Reeh M; Miro JT; Tsui TY; Wellner U; Izbicki JR; Güngör C; Vashist YK
    Apoptosis; 2017 Mar; 22(3):369-380. PubMed ID: 27878398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.
    Singla S; Pippin JA; Drebin JA
    Oncol Rep; 2012 Dec; 28(6):2211-6. PubMed ID: 23007710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
    Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP
    Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells.
    Hagmann W; Jesnowski R; Löhr JM
    Neoplasia; 2010 Sep; 12(9):740-7. PubMed ID: 20824050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2.
    Bellone G; Carbone A; Busso V; Scirelli T; Buffolino A; Smirne C; Novarino A; Bertetto O; Tosetti L; Emanuelli G
    Cancer Biol Ther; 2006 Oct; 5(10):1294-303. PubMed ID: 16929163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.
    Bocci G; Fioravanti A; Orlandi P; Bernardini N; Collecchi P; Del Tacca M; Danesi R
    Br J Cancer; 2005 Aug; 93(3):319-30. PubMed ID: 16052215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes.
    Shi X; Liu S; Kleeff J; Friess H; Büchler MW
    Oncology; 2002; 62(4):354-62. PubMed ID: 12138244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.